| Down |
| 1. | Renin-angiotensin-aldosterone system |
| 2. | Side effects include worst headache from a medication, drop in BP, and decreased oxygen need of heart; used for angina |
| 3. | Thickened and stiffened arterial walls; often comorbid with or caused by atherosclerotic changes |
| 4. | Heparin given to prevent clots, usually via IV route |
| 5. | the product of stroke volume and peripheral resistance |
| 6. | Chest pain or discomfort connected with cardiovascular occlusions or spasms |
| 7. | BP over 140/90, patient under 65 |
| 8. | Diet, lifestyle, activity, medications |
| 13. | occlusion or blockage of bloodflow leads to tissue damage |
| 14. | no known cause |
| 16. | Left sided heart failure effects |
| 17. | Thiazide diuretic |
| 18. | Enoxaparin and Dalteparin |
| 21. | protein released by brain to increase diuresis with increased sodium levels |
| 27. | Stiffened and fibrotic scarring leads to difficulty filling, shape changes |
| 28. | primary assessment of fluid balance in CHF; taken same time daily with same equipment; no increase is good. |
| 29. | Age, race, genetics, gender |
| 30. | MVR |
| 33. | Ring surrounding valve |
| 35. | VTE mechanical prophylaxis |
| 36. | resistance left ventricle has to overcome to circulate (peripheral resistance) |
| 38. | blood remains in artery, possibly between injured layers causing bulge |
| 39. | inflammation of sac that contains heart |
| 42. | volume of blood in ventricles at end of diastole |
| 44. | Ballooning of leaflet into chamber beyond or behind causing regurgitation of flow |
| 46. | reddish-blue discoloration of extremities; related to PAD |
| 51. | Antidote for warfarin |
| 52. | Sticky, spongy, fatty cholesterol |
| 57. | congestive heart failure |